Clinical Application of CT-Guided Percutaneous Microwave Ablation for the Treatment of Lung Metastasis from Colorectal Cancer

Table 3

Literatures related to the ablation of lung metastases from colorectal cancer in recent years.

Author institution	Recruitment period	Characteristics of patients	Patient with LM from CRC	Key outcome^n
Wolf et al. 2008 [24]	2003–2006	; 28 men, 22, women; mean age 70 years	9	Residual disease and recurrent disease of the ablation was 22% and 26%, respectively.
Vogl et al. 2001 [30]	2007–2010	; 30 men, 50 women; mean age 59.7 years	40 (58 lesions)	New metastases developed in patients with colorectal cancer 7.5%.
Lu et al. 2012 [25]	2005–2008	; 45 men, 24 women; mean age 65 years	7	Local progress of masses appeared 21.74%.
Wolf et al. 2012 [31]	2009-2010	; 6 men, 4 women; mean age 71 years	1	The risk of local disease progression was decreased.
Raspanti et al. 2014 [32]	2009–2012	, 36 nodules	21 (36 lesions)	Residual disease was observed about 2.8%.
Vogl et al. 2016 [21]	2000–2014	; 71 men, 38 women; mean age 68.6 years	47 (103 lesions)	Local progress of masses appeared 12%.

LM: lung metastases; CRC: colorectal cancer. ⁿThe histopathologic type of the metastasis was not a statistically significant factor when correlating with the ablation result [25, 30].